KCM
Kynam Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-390,792
| Closed | -$15.1M | – | 32 |
|
|
2024
Q4 | $15.1M | Sell |
390,792
-65,577
| -14% | -$2.53M | 0.89% | 20 |
|
|
2024
Q3 | $20.5M | Sell |
456,369
-343,631
| -43% | -$15.5M | 1.57% | 15 |
|
|
2024
Q2 | $27.7M | Sell |
800,000
-344,242
| -30% | -$11.9M | 2.14% | 9 |
|
|
2024
Q1 | $33.1M | Sell |
1,144,242
-860,633
| -43% | -$24.9M | 3.46% | 10 |
|
|
2023
Q4 | $46M | Buy |
2,004,875
+186,218
| +10% | +$4.27M | 5.09% | 6 |
|
|
2023
Q3 | $30.3M | Buy |
1,818,657
+843,359
| +86% | +$14.1M | 4.96% | 6 |
|
|
2023
Q2 | $26.9M | Sell |
975,298
-399,702
| -29% | -$11M | 3.71% | 7 |
|
|
2023
Q1 | $31.6M | Buy |
1,375,000
+854,078
| +164% | +$19.6M | 4.08% | 8 |
|
|
2022
Q4 | $5.68M | Buy |
520,922
+1,710
| +0.3% | +$18.7K | 0.87% | 19 |
|
|
2022
Q3 | $4.38M | Buy |
+519,212
| New | +$4.38M | 0.92% | 24 |
|